Business Wire

Sigfox Launches World’s First “IoT network-as-a-service”, Bringing IoT Connectivity to Billions of Unconnected Devices

Del

At the Sigfox World IoT Expo, Sigfox reaches a new milestone in the history of IoT, as it launches a suite of new services that will connect billions of wireless devices that are not yet connected to the internet.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170926005774/en/

This game-changing development has been made possible by the cognitive capabilities of the Sigfox network and its Software Define Radio technology, where all the network and computing complexity is managed in the Cloud rather than on the device. This enables Sigfox to constantly improve its network features and make them available by simple software upgrade.

Connecting the unconnected

Admiral Ivory is a simplified connectivity service which now makes it possible to transform any short-range wireless device into a long-range IoT device, with a hardware component as little as $0.20, using something as simple as the silicon chip that you find in a garage door remote control.

Unlike other services currently available on the market, Admiral Ivory opens the door to creating connected, disposable assets and one-time IoT applications. Imagine being able to connect and track small parcels and letters. Through Admiral Ivory, this will be technically and economically possible – presenting a significant opportunity for industrial packing, logistics and retail industries.

This complements Sigfox’s ultra-low-cost connectivity solution, now named Sigfox Admiral Blue. The technology enables inexpensive modules from as little as $2 to send tiny packets of information over long distances, while using very little power.

Together, these services are set to enable millions of entry-level devices to gain internet connectivity.

IoT Connectivity Anywhere: Cognition service

Most IoT applications are sold and operated locally. However, manufacturers looking to export their devices around the world need to be able to deliver devices that can run in any part of the world, if they are to achieve economies of scale.

In response, Sigfox announces its new Sigfox Monarch cognitive service, which offers seamless connectivity worldwide by allowing IoT devices to recognize and automatically adapt to local communications standards.

Sigfox’s technology operates in unlicensed bands worldwide, with radio frequencies ranging from 862 to 928 MHz. Using unlicensed bands enable devices to send their data to the cloud while using little power, at very low cost. Sigfox Monarch provides a unique radio recognition service enabling devices to manage the radio frequency changes, without any additional hardware such as GPS or Wi-Fi chipset.

By enabling ‘globe trotter’ assets that can seamlessly adapt as they move across borders, Monarch represents a game-changer for logistics, freight, and consumer goods industries. Lost luggage will become a distant memory thanks to Sigfox Monarch, as the luggage can be tracked worldwide. It will also allow manufacturers, including consumer electronics and white goods, to have a single hardware design for products sold around the world.

Location service

These new services add an extra layer of functionality and value to the existing Sigfox geolocation service. Atlas, previously known as Sigfox Geolocation, is the world’s lowest cost integrated geolocation function. It uses radio-signal analysis to determine the device’s location. Unlike GPS, the service does not increase power consumption and requires no extra hardware, beyond the already-integrated Sigfox chip.

Ludovic Le Moan, CEO at Sigfox, said, “Each of these services radically reduce the costs and barriers to entry for manufacturers that want to break into the IoT market. Manufacturers will benefit from faster time to market, lower cost of production and the ability to deliver greater customization for each device.”

New simplified onboarding process

In addition to its newly announced services, Sigfox has also launched a new, streamlined, onboarding process, Sigfox Sunrise. Designed to help partners cut their development time and costs, Sunrise includes:

  • Sigfox Partner Network: the one-stop source for all resources partners need for their IoT project, from hardware to devices, development kits, platforms and end-to-end solutions. More information at https://partners.sigfox.com
  • Sigfox BUILD: an online portal dedicated to supporting device makers and solution providers at every stage of their journey, from designing to certification and scalability of IoT projects. More information at https://build.sigfox.com
  • Sigfox BUY: this new service makes it easy and fast for partners, developers, universities, anyone to quickly buy Sigfox devices and connect them to the Sigfox global IoT network, with a starter offer at 10 devices. More information at https://buy.sigfox.com

- ENDS –

About Sigfox
Sigfox is the world’s leading provider of connectivity for the Internet of Things (IoT). The company has built a global network to connect billions of devices to the Internet while consuming as little energy as possible, as simply as possible. Sigfox’s unique approach to device-to-cloud communications addresses the three greatest barriers to global IoT adoption: cost, energy consumption, and global scalability.

Today, the network is present in 36 countries and on track to cover 60 by 2018 – covering a population of 660 million people. With millions of objects connected and a rapidly growing partner ecosystem, Sigfox empowers companies to move their business model towards more digital services. Founded in 2010 by Ludovic Le Moan and Christophe Fourtet, the company is headquartered in Labège near Toulouse, France’s “IoT Valley”. Sigfox also has offices in Paris, Madrid, Munich, Boston, San Francisco, Dubai, Singapore and Tokyo. For more information, see www.sigfox.com and follow us on Twitter, Facebook and YouTube.

https://www.sigfox.com/en/news/sigfox-launches-worlds-first-iot-network-service-bringing-iot-connectivity-billions

Contact information

Press
Sigfox
Laurence Collet, Ornella Bersanetti
press@sigfox.com
or
Edelman for Sigfox
Simon Chan, +44 (0)7875 198 091
simon.chan@edelman.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Andersen Global Expands Presence in Germany with Addition of Thierhoff Müller & Partner13.12.2017 08:01Pressemelding

Andersen Global is proud to announce an expanded presence in Germany as Thierhoff Müller & Partner, a tax and legal firm with offices in Leipzig and Frankfurt, combines its practice with Andersen Tax & Legal in Germany. Through its German member firms, Andersen Tax & Legal and Alegis Steuerberatungsgesellschaft mbH, Andersen Global now has more than 65 professionals focused on providing tax and legal services and business advice across five locations in Germany, including Cologne, Dusseldorf, and Merzig. “Thierhoff Müller is highly regarded in complex restructuring matters. Together with our existing legal and tax practice, we will be able to increase our service offerings for our clients,” said Stefan Kraus, Managing Partner of Andersen Tax & Legal in Germany. “We are dedicated to providing outstanding service and are adding additional competencies in tax and legal such as corporate r

Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs13.12.2017 08:00Pressemelding

Aprecia Pharmaceuticals, LLC (“Aprecia”), The 3DP Pharmaceutical Company, and Cycle Pharmaceuticals, Ltd. (“Cycle”) today announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose® Technology platform. ZipDose® is the only three-dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration. Antonio Benedetti, CEO of Cycle commented: “Many rare disease patients do not have a treatment option at all. For those rare diseases where there is an approved pharmaceutical treatment, patients continue to be burdened by sub-optimal drug formulations. Aprecia’s

Group Vivendi Africa Deploys Netcracker OSS to Enhance Service Management as it Expands Across the Continent12.12.2017 16:07Pressemelding

Netcracker Technology announced today that its OSS suite was selected and deployed to support the long-term growth strategy of Group Vivendi Africa (GVA). GVA is a newly formed affiliate of the French-based multinational conglomerate Vivendi with the goal to deploy and operate a fiber network across Africa. Netcracker's OSS will be used as a consolidated solution to identify service availability across GVA's operating countries and then fulfill and provision those services to customers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005937/en/ Netcracker's highly productized, out-of-the-box applications enabled the OSS suite to be deployed in seven months, meeting GVA's demand to leverage an integrated service fulfillment and inventory solution that could satisfy its long-term growth expectations, as well as s

Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program12.12.2017 15:23Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/ Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire) This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s

Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00Pressemelding

Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid

Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33Pressemelding

Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom